Latest medical news · page 16

When Families Are Not the Barrier to Clinical Trial Enrollment

Pediatrics

Probiotic-Associated Invasive Infection Among Preterm Infants

This cohort study examines the incidence of invasive bacterial infection associated with probiotic supplementation among preterm infants.

Patient and Clinician HRQOL Perceptions in Urinary Tract Infections

This qualitative study compares perceptions between patients with complicated urinary tract infection and their treating clinicians about the patients’ health-related quality of life (HRQOL).

Guns and Perceptions of Safety Among US Women

This survey study examines perceptions of safety related to firearm ownership among women in the US.

Remote Patient Monitoring for Hypertension Among Medicare Beneficiaries

This cohort study compares adoption of remote patient monitoring among Medicare beneficiaries who continued a fee-for-service plan vs those who switched to a Medicare Advantage plan.

Clinical Trial Participation Among Families From Historically Marginalized Groups

This cross-sectional study collects and analyzes clinician and parent perspectives on pediatric oncology clinical trial participation among children from historically marginalized groups.

Diagnostic Stewardship of PICU Respiratory Cultures Using Clinical Decision Support

This cohort study evaluates the association of diagnostic stewardship of endotracheal aspirate cultures using clinical decision support with culture rates, antibiotic use, and patient outcomes across a multicenter collaborative of pediatric intensive care units (PICUs).

Neighborhood Environmental Interventions and Opioid Overdose Rates

This nonrandomized clinical trial evaluates the association of neighborhood environmental interventions with opioid overdose rates in Philadelphia, Pennsylvania.

Cognitive Outcomes After Catheter Ablation for Atrial Fibrillation

This cohort study evaluates changes in global and domain-specific cognitive function after catheter ablation for atrial fibrillation.

We Are Rats; If Pharma Could Be Brave … And Other Bullseye POVs You Won’t Hear at Other Events

MedCity News’ new event for healthcare investors and corporate business development leads — Bullseye — hit the mark when it comes to provocative and thoughtful commentary. Here’s what was said in panels throughout the day. The post We Are Rats; If Pharma Could Be Brave … And Other Bullseye POVs You Won’t Hear at Other Events appeared first on MedCity News .

Gloria Pina

Gloria Pina Anonymous (not verified) Thu, 07/30/2026 - 22:02 Profession Mental Health Counselor Telemedicine On Description Private practice counseling service supporting clients as a mental health professional. I also have a desire to offer behavioral health support to PWD. Phone 509-472-0657 Website https://gloria-pina.clientsecure.me/ Special Interest Diabetes Distress Type 1 Diabetes Type 2 Diabetes Insurance Out of Pocket (Self-Pay) Sliding scale Off Adult service On Pediatric Services Off Accepts Insurance On Address 144 Erica Dr Richland , WA 99352 United States Address Geocoded POINT…

BD Issues Nationwide Recall for Specific Lots of BD® Intraosseous Vascular Access System Needle Sets Due to Reports of Difficulty Removing the Obturator

FRANKLIN LAKES, N.J. (July 31, 2026) – BD (Becton, Dickinson and Company) is voluntarily recalling specific lots of BD® Intraosseous Vascular Access System Needle Sets to the user level. These products are being recalled following reports that some users experienced difficulty removing the obturato

Why Hims & Hers Is Embroiled in Yet Another Controversy, This Time with the FTC

The FTC and the states of Utah and California sued Hims & Hers, alleging it improperly shared consumers’ health information and misled customers about billing, subscriptions and cancellations. The post Why Hims & Hers Is Embroiled in Yet Another Controversy, This Time with the FTC appeared first on MedCity News .

Future family physicians challenged to write health care's next chapter

J&J Joins Immune Reset Race, Paying $785M to Partner on Sail Bio Cell Therapy

Johnson & Johnson also gains an exclusive option to acquire Sail Biosciences for $2.58 billion. The deal puts J&J in the mix of pharmaceutical companies developing next-generation cell therapies for applications in autoimmune diseases. The post J&J Joins Immune Reset Race, Paying $785M to Partner on Sail Bio Cell Therapy appeared first on MedCity News .

Replimune’s twice-rejected melanoma drug prevails in FDA adcomm

Following a pair of FDA rejections of its melanoma drug, Replimune’s fortunes flipped today after an advisory committee voted 10 to 3 in favor of the candidate’s effectiveness.

Ukrop’s Homestyle Foods Announces a Voluntary Recall Due to Possible Foreign Object

Richmond, VA – Ukrop's Homestyle Foods, LLC today is voluntarily recalling six of its products due to the potential presence of a foreign object.

Effect of Diagnostic Test Type on Detection of Salmonella Infections - Foodborne Diseases Active Surveillance Network, 2004-2024

The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC).

West Nile Virus and Other Nationally Notifiable Arboviral Diseases - United States, 2024

The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC).

Meet Ann: Living, Learning, and Advocating with Type 2 Diabetes

Meet Ann: Living, Learning, and Advocating with Type 2 Diabetes mseibold Thu, 07/30/2026 - 16:56 Type 2 Advocacy Share Your Story By sharing your story, you help us raise awareness of diabetes so we can bend the curve on it once and for all. Will you help us awaken the world? Share Your Story

Chutes & Ladders—Legend CEO departs without successor in place

Legend Biotech CEO Ying Huang, Ph.D., has left the company suddenly, without a predecessor in place. Huang was elevated from CFO to CEO in 2020 after a Chinese customs investigation was opened on founding CEO Fangliang Zhang, Ph.D.

FTC sues Hims & Hers over alleged privacy violations, deceptive billing practices

Regulators say the telehealth company illegally shared patient health data with advertisers and misled its customers. Hims & Hers hit back, calling the claims “baseless.”

New leadership team appointments

EMA’s Head of the Stakeholders…, A new Head of the Veterinary…, Ivo Claassen joined EMA in 2018. Among many career highlights, Ivo and his team worked with the veterinary medicines network on the successful implementation of the 2019…

ACC’s 2027 Medicare Physician Fee Schedule Proposed Rule Calculator Now Available

Work, practice, expense and liability relative value units (RVUs) are updated annually through the Centers for Medicare and Medicaid Services' (CMS') Physician Fee Schedule (PFS) rulemaking. In response to the recently released 2027 Medicare PFS proposed rule, your ACC has developed a PFS calculator so clinicians and practice managers can estimate the potential impact of changes to their practices.